![Kumar Srinivasan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kumar Srinivasan
Directeur Général chez
Wugen, Inc.
Fortune : 6 048 $ au 31/05/2026
Profil
Kumar Srinivasan is President, Chief Executive Officer & Director at Wugen, Inc. since 2023.
Dr. Srinivasan is Director at Pulmotect, Inc. Former roles include Independent Non-Executive Director at Transcenta Holding Ltd. from 2022 to 2026, and Chief Business Officer & Executive Vice President at Turning Point Therapeutics, Inc. Education includes a doctorate from Case Western Reserve University, undergraduate and graduate degrees from the University of Madras, and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2026 | 30 000 ( 0,01% ) | 6 048 $ | 31/05/2026 |
Postes actifs de Kumar Srinivasan
| Sociétés | Poste | Début |
|---|---|---|
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Directeur/Membre du Conseil | - |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Directeur Général | 13/03/2023 |
Anciens postes connus de Kumar Srinivasan
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur/Membre du Conseil | 30/06/2026 |
| TURG POIN | Corporate Officer/Principal | - |
Formation de Kumar Srinivasan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Health Technology |
Transcenta Holding Ltd.
 Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Technology Services |
Choisissez Zonebourse 
